Risk Factor Questionnaire
OtherParticipants, both cases and controls, will complete the CYOC risk factor questionnaire, preferably at the time of first visit
Other names: CYOC Risk Factor Questionnaire
NCT Number: NCT04489238
The purpose of this registry study is to create a database-a collection of information-for better understanding young onset colorectal cancer. Colorectal cancer patients are considered to have young onset colorectal cancer if they are diagnosed with their cancer before the age of 50. Researchers will use the information from this database to learn more about how young onset colorectal cancer may be similar to or different from colorectal cancer that is diagnosed later in life. Researchers will also use information from the database for current and future research on young onset colorectal cancer.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Participant Inclusion Criteria for database and questionnaire (YOGI)
Participant Inclusion Criteria for database and questionnaire (Controls)
Participants, both cases and controls, will complete the CYOC risk factor questionnaire, preferably at the time of first visit
Other names: CYOC Risk Factor Questionnaire
Time frame: 1 year
from diagnosis through survivorship
Contact information is provided by the study sponsor or research team.
Andrea Cercek, MD
CONTACT
Rona Yaeger, MD
CONTACT
Memorial Sloan Kettering Cancer Center
Other
Young Onset Gastrointestinal Cancer Prospective Registry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05786924
Acquired Resistance to KRAS G12C Inhibitor, BRAF
Gilbert, Arizona, United States
View Trial DetailsNCT04812912
Colonic Diseases, Colorectal Cancer
Basking Ridge, New Jersey, United States
View Trial DetailsNCT04912765
Adenocarcinoma, Carcinoma
Singapore
View Trial DetailsNCT06640166
Colon Adenocarcinoma, Colon Cancer
Milan, Italy
View Trial Details